CN Patent

CN117942309A — 沙库巴曲缬沙坦钠与达格列净双层片剂的制备方法

Assigned to Jiangsu Litaer Pharmaceutical Co ltd · Expires 2024-04-30 · 2y expired

What this patent protects

本发明涉及一种沙库巴曲缬沙坦钠与达格列净双层片剂的制备方法，所述双层片剂包含作为第一层的质量得以减小的沙库巴曲缬沙坦钠制剂，包含沙库巴曲缬沙坦钠、填充剂、稳定剂、崩解剂、润滑剂，其中，稳定剂为预胶化淀粉；作为第二层的达格列净制剂，包含达格列净、填充剂、崩解剂、润滑剂。该方法得到的双层片剂稳定性好，工艺简单，生产成本低，适合于规模化生产。

USPTO Abstract

本发明涉及一种沙库巴曲缬沙坦钠与达格列净双层片剂的制备方法，所述双层片剂包含作为第一层的质量得以减小的沙库巴曲缬沙坦钠制剂，包含沙库巴曲缬沙坦钠、填充剂、稳定剂、崩解剂、润滑剂，其中，稳定剂为预胶化淀粉；作为第二层的达格列净制剂，包含达格列净、填充剂、崩解剂、润滑剂。该方法得到的双层片剂稳定性好，工艺简单，生产成本低，适合于规模化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN117942309A
Jurisdiction
CN
Classification
—
Expires
2024-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Litaer Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.